# Nora Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nora-therapeutics

- Industry: Pharmaceuticals
- Headquarters: Palo Alto, US
- Website: www.noratherapeutics.com
- Total disclosed funding: $43M
- Latest round: Series B (Apr 11, 2014)
- Investors on record: 5

## About

Founded in 1992, Nora Therapeutics is a US-based biotechnology company focused on developing innovative therapeutic solutions for conditions requiring advanced treatment options.Nora Therapeutics specializes in biopharmaceuticals, aiming to create effective therapies for various medical conditions. The company was founded in Palo Alto, US, in 1992. It has completed a total of 5 deals since its inception. The most recent funding round occurred on October 13, 2015, where the company raised USD 1 mn in VENTURE DEBT funding, contributing to a total amount raised of USD 18 mn.Nora Therapeutics plans to leverage the recent funding obtained in October 2015 to support the development of new therapeutic products. While specific products or launch dates have not been disclosed, the company is expected to explore expansion into new geographical regions in the near future.

## Funding rounds

- Series B, Apr 11, 2014, $18M — Burrill & Company, Prospect Venture Partners, RHO, Vivo Capital, Novo Holdings
- Series A, Oct 1, 2008, $25M — Burrill & Company, Prospect Venture Partners, Vivo Capital

## Investors

- Burrill & Company (https://capitalatlas.ai/funds/burrill-company) — Series A, Series B
- Prospect Venture Partners (https://capitalatlas.ai/funds/prospect-venture-partners) — Series A, Series B
- Vivo Capital (https://capitalatlas.ai/funds/vivo-capital) — Series A, Series B
- RHO (https://capitalatlas.ai/funds/rho) — Series B
- Novo Holdings — Series B